Risk-adapted individual LDL-C targets

Together with arterial hypertension and diabetes mellitus, lipid metabolism disorders are among the most important modifiable cardiovascular risk factors. In addition to statins, various modern substance classes are now available for lowering LDL-C levels with medication. Through an adapted step therapy, the respective target values can be achieved in many patients, also in secondary prevention after acute coronary syndrome (ACS).